Shorter antibiotic regimens impact the control efforts in high tuberculosis burden regions of Taiwan

Shorter antibiotic regimens impact the control efforts in high tuberculosis burden regions of Taiwan

Objectives: To assess the potential epidemiological impact and cost-effectiveness of shorter antibiotic regimens in high tuberculosis (TB) burden regions of Taiwan. Methods: This study combined the TB population dynamic model and cost-effectiveness analysis with local data to simulate the disease bu...

Full description

Bibliographic Details
Main Authors:	Yi-Jun Lin, Hsing-Chieh Lin, Ying-Fei Yang, Chi-Yun Chen, Tien-Hsuan Lu, Chung-Min Liao
Format:	Article
Language:	English
Published:	Elsevier 2020-08-01
Series:	International Journal of Infectious Diseases
Subjects:	Tuberculosis Economic evaluation Population dynamic model Antibiotic treatment Shorter regimens
Online Access:	http://www.sciencedirect.com/science/article/pii/S1201971220303891

Similar Items

Limited Scope of Shorter Drug Regimen for MDR TB Caused by High Resistance to Fluoroquinolone
by: Pravin K. Singh, et al.
Published: (2019-09-01)

Applicability of the shorter ‘Bangladesh regimen’ in high multidrug-resistant tuberculosis settings
by: Giovanni Sotgiu, et al.
Published: (2017-03-01)

Treatment of Drug-Resistant Tuberculosis: Current Status
by: Rajendra Prasad, et al.
Published: (2021-04-01)

Effectiveness and Safety of a Shorter Treatment Regimen in a Setting with a High Burden of Multidrug-Resistant Tuberculosis
by: Aleksandr Trubnikov, et al.
Published: (2021-04-01)

Initial resistance to companion drugs should not be considered an exclusion criterion for the shorter multidrug-resistant tuberculosis treatment regimen
by: Pauline Lempens, et al.
Published: (2020-11-01)

Extrapulmonary drug-resistant tuberculosis at a drug-resistant tuberculosis center, Mumbai: Our experience – Hope in the midst of despair!
by: Unnati Desai, et al.
Published: (2019-01-01)

Shorter treatment for minimal tuberculosis (TB) in children (SHINE): a study protocol for a randomised controlled trial
by: Chishala Chabala, et al.
Published: (2018-04-01)

Effectiveness of the shorter MDR regimen in the management of tuberculosis: Shortfall in the outcome of disease a multidimensional approach and evaluation for a better alternative
by: Prasanta Kumar Das, et al.
Published: (2020-01-01)

Initial resistance to companion drugs should not be considered an exclusion criterion for the multidrug-resistant tuberculosis shorter treatment regimen
by: Lempens, P., et al.
Published: (2020)

Multidrug-resistant tuberculosis/rifampicin-resistant tuberculosis: Principles of management
by: Rajendra Prasad, et al.
Published: (2018-01-01)

Effectiveness and safety of fully oral modified shorter treatment regimen for multidrug-resistant tuberculosis in Georgia, 2019-2020
by: Teona Avaliani, et al.
Published: (2021-01-01)

Delamanid, linezolid, levofloxacin, and pyrazinamide for the treatment of patients with fluoroquinolone-sensitive multidrug-resistant tuberculosis (Treatment Shortening of MDR-TB Using Existing and New Drugs, MDR-END): study protocol for a phase II/III, multicenter, randomized, open-label clinical trial
by: Myungsun Lee, et al.
Published: (2019-01-01)

Shorter drug regimen of multidrug-resistant tuberculosis and the ambiguity in the World Health Organization recommendations
by: Rabbanie Tariq Wani, et al.
Published: (2019-01-01)

Hyperopic anisometropia with a shorter axial length ipsilateral to the ptotic eye in children with congenital ptosis
by: Satoshi Ueki, et al.
Published: (2021-10-01)

Ableist Constructions of Time? Boys and Men with Duchenne Muscular Dystrophy Managing the Uncertainty of a Shorter Life
by: Thomas Abrams, et al.
Published: (2020-03-01)

A proof-of-concept study in HCV-infected Huh7.5 cells for shortening the duration of DAA-based triple treatment regimens
by: Hu Li, et al.
Published: (2019-08-01)

Discrimination of Urban Spaces with Different Level of Restorativeness Based on the Original and on a Shorter Version of Hartig et al.’s Perceived Restorativeness Scale
by: Fátima Negrín, et al.
Published: (2017-10-01)

The Effect of KatG S315t M. Tuberculosis Gene Mutation on Conversion Rate of MDR-TB Patients with Shorter-Course Treatment
by: Raden Ayu Linda Andriani, et al.
Published: (2020-10-01)

New regimens and new medications in the treatment of tuberculosis: keeping step?
by: Ruzanov D.Y., et al.
Published: (2021-04-01)

A Pilot Study of Antibiotic Regimens for Infections Caused by Acinetobacter baumannii in a Secondary Hospital in Thailand
by: Suphansatit R, et al.
Published: (2020-12-01)

Spanish Validation of the Shorter Version of the Workplace Incivility Scale: An Employment Status Invariant Measure
by: Donatella Di Marco, et al.
Published: (2018-06-01)

Estimating the impact of a novel drug regimen for treatment of tuberculosis: a modeling analysis of projected patient outcomes and epidemiological considerations
by: Emily A. Kendall, et al.
Published: (2019-09-01)

Pretomanid: Clinical Trials and Prospects to Be Used in Treatment Regimens for Multiple and Extensive Drug Resistant Tuberculosis
by: A. V. Kukurika
Published: (2021-07-01)

Rapid assessment of facilitators and barriers related to the acceptance, challenges and community perception of daily regimen for treating tuberculosis in India
by: Himanshu Negandhi, et al.
Published: (2017-01-01)

Treatment of community-onset pneumonia in neutropenic cancer patients: β-lactam monotherapy versus combination antibiotic regimens
by: Hyeri Seok, et al.
Published: (2019-06-01)

Sequencing Shorter cfDNA Fragments Decreases the False Negative Rate of Non-invasive Prenatal Testing
by: Ying Xue, et al.
Published: (2020-03-01)

An optimized background regimen design to evaluate the contribution of levofloxacin to multidrug-resistant tuberculosis treatment regimens: study protocol for a randomized controlled trial
by: Tara C. Bouton, et al.
Published: (2017-11-01)

High Levels of Treatment Success and Zero Relapse in Multidrug-Resistant Tuberculosis Patients Receiving a Levofloxacin-Based Shorter Treatment Regimen in Vietnam
by: Le T. N. Anh, et al.
Published: (2020-03-01)

Short-Course Regimen for Multidrug-Resistant Tuberculosis: A Decade of Evidence
by: Arnaud Trébucq, et al.
Published: (2019-12-01)

Towards tailored regimens in the treatment of drug-resistant tuberculosis: a retrospective study in two Italian reference Centres
by: Niccolò Riccardi, et al.
Published: (2019-06-01)

The Appropriate DOTS Regimen Greatly Reduces the Disabilities in Polyarticular EPTB
by: Arvnd S. Pandey, et al.
Published: (2013-03-01)

Course of Adverse Events during Short Treatment Regimen in Patients with Rifampicin-Resistant Tuberculosis in Burundi
by: François Ciza, et al.
Published: (2020-06-01)

Assessment of Adherence to Anti-Tuberculosis Treatment among Patients with Tuberculosis in Qom Province in 2019 (Iran)
by: Seyed Abbas Hosseinalipour, et al.
Published: (2020-03-01)

Real‐world data of Helicobacter pylori prevalence, eradication regimens, and antibiotic resistance in Thailand, 2013–2018
by: Rossanun Shoosanglertwijit, et al.
Published: (2020-02-01)

Tedizolid, Faropenem, and Moxifloxacin Combination With Potential Activity Against Nonreplicating Mycobacterium tuberculosis
by: Shashikant Srivastava, et al.
Published: (2021-01-01)

Simplified antibiotic regimens for treating neonates and young infants with severe infections in the Democratic Republic of Congo: a comparative efficacy trial
by: Adrien Lokangaka, et al.
Published: (2018-04-01)

Gambaran Kepatuhan Pasien Tuberkulosis Paru Terhadap Regimen Terapeutik Di Puskesmas Padasuka
by: Safii Safii, et al.
Published: (2018-01-01)

Tuberculosis treatment outcomes of six and eight month treatment regimens in districts of Southwestern Ethiopia: a comparative cross-sectional study
by: Abyot Asres, et al.
Published: (2016-11-01)

Heterogeneity of Mycobacterium tuberculosis drug resistance in respect of pharmacokinetics of anti-tuberculosis drugs as a basis for individual treatment regimen
by: S. A. Popov, et al.
Published: (2015-04-01)

Modern approaches to initial chemotherapy regimens in older children, adolescents and patients with destructive pulmonary tuberculosis
by: E. S. Ovsyankina, et al.
Published: (2013-12-01)